STM Journals Peer-reviewed research from Consortium e-Learning Network

Journal of Nanoscience, NanoEngineering & Applications

Nanotechnology: Applications in Regenerative Medicine

  1. Mehamalini V.
  2. Divyansh Gupta

Abstract

Nanotechnology presently has many uses in practically every one of the fields. The introduction of nanomedicine has benefitted many research areas in pharmaceutical industries. The usage of nanoparticles in drugs has shown great results that the other drugs did not. In the development of novel medicine, nanotechnology is playing an important role. It is because few medications cannot be used due to complications such as its toxicity, this can be replaced by a nanomedicine. Nanomedicine which contains nanoparticles, has higher surface to volume ratio (aspect ratio). Nanomedicine has shown its effectiveness in both diagnostics and therapeutics. In this review article the use of nanomedicine as an effective regenerative medicine will be discussed. Tissue engineering-mimic of the natural tissues in our body, cellular therapies, artificial organ transplant will also be discussed. Few of the application s of tissue engineering is also mentioned.

Keywords

References (27)

  1. Dinnyes Andras, et al. Integration of nano -and biotechnology for beta -cell and islet transplantation in type-1 diabetes treatment. Cell Prolif. 2020; 53(5): e12785.
  2. Petersmann Astrid, et al. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2019; 127.S 01: S1–S7.
  3. Aguayo-Mazzucato Cristina, Susan Bonner -Weir. Pancreatic β cell regeneration as a possible therapy for diabetes. Cell Metab. 2018; 27(1): 57–67.
  4. Contera, Biotechnology. Nanotechnology and medicine, Emerg Top Life Sci . Availab le at: https://doi. org/10.1042/ETLS20200350.
  5. Veritti, Daniele, Valentina Sarao, and Paolo Lanzetta. "A propensity -score matching comparison between 27 -gauge and 25 -gauge vitrectomy systems for the repair of primary rhegmatogenous retinal detachment." Journal of Ophthalmology 2019 (2019).
  6. Constantin Brănişteanu Daniel, Bilha Andrei, Moraru Andreea. Vitrectomy surgery of diabetic retinopathy complications. Rom J Ophthalmol. 2016; 60(1): 31.
  7. Deschler Emily K , Jennifer K. Sun, Paolo S. Silva. Side-effects and complications of laser treatment in diabetic retinal disease. Semin Ophthalmol. 29(5-6). Taylor & Francis, 2014.
  8. Farokhzad Omid C , Robert Langer. Impact of nanotechnology on drug delivery. ACS Nano. 2009; 3(1): 16–20.
  9. Chen Guangcun, et al. Recent advances in tracking the transplanted stem cells using near-infrared fluorescent nanoprobes: turning from the first to the second near -infrared window. Adv Healthc Mater. 2018; 7(20): 1800497.
  10. Garbayo Elisa, et al. Nanomedicine and drug delivery systems in cancer and regenerative medicine. Wiley Interdiscip Rev: Nanomed Nanobiotechnol. 2020; 12(5): e1637.
  11. Bahmad Hisham F, Robert Poppiti, John Alexis. Nanotherapeutic approach to treat diabetic foot ulcers using tissue -engineered nanofiber skin substitutes: a review. Diabetes Metab Syndr: Clinical Research & Reviews. 2021; 15(2): 487–491.
  12. Kim Jong Hyun, et al. Nanotopographical regulation of pancreatic islet -like cluster formation from human pluripotent stem cells using a gradient -pattern chip. Acta Biomaterialia. 2019; 95: 337–347.
  13. Cierpka-Kmiec Katarzyna, Agata Wronska, Zbigniew Kmiec. In vitro generation of pancreatic β- cells for diabetes treatment. I. β -like cells derived from human pluripotent stem cells. Folia histochemica et cytobiologica. 2019; 57(1): 1–14.
  14. Pinzi Luca, Giulio Rastelli. Molecular docking: shifting paradigms in drug discovery. Int J Mol Sci. 2019; 20(18): 4331.
  15. Heng LZ, et al. Diabetic retinopathy: pathogenesis, clinical grading, management and future developments. Diabet Med. 2013; 30(6): 640–650.
  16. Shanik Michael H, et al. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse? Diabetes care 2008; 31. Supplement_2: S262–S268.
  17. Budzinskaya MV, et al. On classification of diabetic retinopathy. Vestn Oftalmol. 2019; 135(5). Vyp. 2: 272–277. Journal of Nanoscience, Nanoengineering & Applications Volume 12, Issue 2 ISSN: 2231-1777 (Online), ISSN: 2321-5194 (Print) © STM Journals 2022. All Rights Reserved 5
  18. Maleki Hassan, et al. Nanofiber-based systems intended for diabetes. J Nanobiotechnol. 2021; 19(1): 1–34.
  19. He Qin, et al. Mesenchymal stem cell -derived exosomal miR -146a reverses diabetic β -cell dedifferentiation. Stem cell Res Ther. 2021; 12(1): 1–16.
  20. Zhou Qiao, Douglas A. Melton. Pancreas regeneration. Nature. 2018; 557(7705): 351–358.
  21. Sabek Omaima M , et al. Three-dimensional printed polymeric system to encapsulate human mesenchymal stem cells differentiated into islet -like insulin -producing aggregates for diabetes treatment. J Tissue Eng. 2016; 7: 2041731416638198.
  22. Nakashima Tadaaki, et al. TLR4 is a critical regulator of angiotensin II -induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase. Hypertens Res. 2015; 38(10): 649–655.
  23. Barkai Uriel, Avi Rotem, Paul de Vos. Survival of encapsulated islets: More than a membrane story. World J Transplant. 2016; 6(1): 69.
  24. Gao Yu, et al. Stem cell tracking with optically active nanoparticles. Am J Nucl Med Mol Imaging. 2013; 3(3): 232.
  25. Wang Yingjie, et al. Assessing in vitro stem -cell function and tracking engraftment of stem cells in ischaemic hearts by using novel iRFP gene labelling. J Cell Mol Med. 2014; 18(9): 1889–1894.
  26. Yamaguchi Yoko, Rie Igarashi. Nanotechnology for therapy of type 2 diabetes. Nihon Rinsho. Jap J Clin Med. 2006; 64(2): 295–300.
  27. Naruse Zeon, Hiroyuki Shimada, Ryusaburo Mori. Surgical outcomes of 27 -gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy. Int Ophthalmol. 2019; 39(9): 1973– 1980.
Support